These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1390319)

  • 21. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials.
    Atkins D; Psaty BM; Koepsell TD; Longstreth WT; Larson EB
    Ann Intern Med; 1993 Jul; 119(2):136-45. PubMed ID: 8305001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence.
    Preiss D; Sattar N
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):815-28. PubMed ID: 19067719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
    Muldoon MF; Manuck SB; Matthews KA
    BMJ; 1990 Aug; 301(6747):309-14. PubMed ID: 2144195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.
    Gotto AM; Grundy SM
    Circulation; 1999 Mar; 99(8):E1-7. PubMed ID: 10051310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trials of replacing saturated fatty acids with n-6 polyunsaturated fatty acids in coronary heart disease prevention: Not the gold standard?
    Virtanen JK
    Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():8-15. PubMed ID: 29789131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin trials and goals of cholesterol-lowering therapy after AMI.
    Pedersen TR
    Am Heart J; 1999 Aug; 138(2 Pt 2):S177-82. PubMed ID: 10426879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?
    Jones PH
    Drugs; 2000 May; 59(5):1127-35. PubMed ID: 10852644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of non-high-density lipoprotein cholesterol for mortality in patients with coronary heart disease: A systematic review and meta-analysis.
    Liao P; Zeng R; Zhao X; Guo L; Zhang M
    Int J Cardiol; 2017 Jan; 227():950-955. PubMed ID: 27939140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low glycaemic index diets for coronary heart disease.
    Kelly S; Frost G; Whittaker V; Summerbell C
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004467. PubMed ID: 15495112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies.
    Tyroler HA
    Am J Med; 1989 Oct; 87(4A):14S-19S. PubMed ID: 2679079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol reduction and death from non-coronary causes: evidence from randomised controlled trials.
    MacMahon S
    Aust N Z J Med; 1994 Feb; 24(1):120-3. PubMed ID: 8002850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol reduction and its impact on coronary artery disease and total mortality.
    Holme I
    Am J Cardiol; 1995 Sep; 76(9):10C-17C. PubMed ID: 7572677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
    Vessby B; Lithell H; Boberg J
    Artery; 1981; 9(5):372-81. PubMed ID: 7032466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.
    Kronmal RA; Cain KC; Ye Z; Omenn GS
    Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.